NEOGEN CORP

NEOGEN CORP (ticker NEOG) stands as a global, publicly traded provider of in vitro and in vivo diagnostic substances, offering an array of reagents, culture media, test kits, and automated instrumentation platforms tailored to food safety, agricultural, and clinical research laboratories under the SIC 2834 pharmaceutical preparations backdrop; CIK 711377 underscores its public accountability while the firm’s latest Form 10-Q filed in October 1999 reflects a legacy of regulatory filings that continue to inform investors about seasonal demand shifts, integration of new assay chemistries, and ongoing compliance with FDA and foreign agency approvals. Its customers span food processors, animal health specialists, and hospital reference labs that value rigorous traceability, rapid turnaround, and global support programs, yet NEOGEN must navigate material risks such as supply-chain volatility, evolving biosafety protocols, and pricing pressures tied to reimbursement policies. Please view live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025